What is the share price of Mankind Pharma Ltd (MANKIND) today?
The share price of MANKIND as on 5th December 2025 is ₹2193.20. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Mankind Pharma Ltd (MANKIND) share?
The past returns of Mankind Pharma Ltd (MANKIND) share are- Past 1 week: -2.48%
- Past 1 month: -7.95%
- Past 3 months: -14.11%
- Past 6 months: -5.95%
- Past 1 year: -15.02%
- Past 3 years: N/A%
- Past 5 years: 55.12%
What are the peers or stocks similar to Mankind Pharma Ltd (MANKIND)?
The peers or stocks similar to Mankind Pharma Ltd (MANKIND) include:What is the market cap of Mankind Pharma Ltd (MANKIND) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Mankind Pharma Ltd (MANKIND) is ₹91077.18 Cr as of 5th December 2025.What is the 52 week high and low of Mankind Pharma Ltd (MANKIND) share?
The 52-week high of Mankind Pharma Ltd (MANKIND) is ₹3054.80 and the 52-week low is ₹2115.10.What is the PE and PB ratio of Mankind Pharma Ltd (MANKIND) stock?
The P/E (price-to-earnings) ratio of Mankind Pharma Ltd (MANKIND) is 45.75. The P/B (price-to-book) ratio is 6.25.Which sector does Mankind Pharma Ltd (MANKIND) belong to?
Mankind Pharma Ltd (MANKIND) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Mankind Pharma Ltd (MANKIND) shares?
You can directly buy Mankind Pharma Ltd (MANKIND) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Mankind Pharma Ltd
MANKIND Share Price
MANKIND Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
MANKIND Performance & Key Metrics
MANKIND Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 52.02 | 6.25 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.94 | 5.83 | 0.58% |
from 16 analysts
Price Upside
Earnings Growth
Rev. Growth
MANKIND Company Profile
Mankind Pharma Ltd develops and markets a wide range of pharmaceutical formulations across various therapeutic areas, including anti-infectives and cardiovascular products.
MANKIND Sentiment Analysis
MANKIND Sentiment Analysis
MANKIND Stock Summary · November 2025
Mankind Pharma demonstrated resilience with a 21% year-on-year revenue increase in Q2 FY '26, driven by strong domestic growth, particularly in chronic segments, despite facing challenges such as supply chain disruptions and a decline in gross margins. The company is strategically enhancing its market position through facility expansions and improved prescriber penetration, while also investing in R&D to foster innovation. However, rising employee costs and integration challenges have pressured profitability, leading to a 21.3% decline in profit after tax. Despite these hurdles, management remains optimistic about achieving double-digit growth in the domestic formulation business, emphasizing a commitment to long-term transformation and operational efficiency.
MANKIND Stock Growth Drivers
MANKIND Stock Growth Drivers
8Strong Revenue Growth
Mankind Pharma has reported significant revenue growth, with a 21% year-on-year increase in Q2 FY
Improved Market Position
The company has achieved a notable improvement in its market position, with its chronic share
MANKIND Stock Challenges
MANKIND Stock Challenges
5Declining Revenue and Profitability
Mankind Pharma's OTC business revenue declined by 3% year-on-year, attributed to supply chain disruptions and
Increased Costs and Financial Pressures
The company has faced rising employee costs due to increased headcount and restructuring efforts, leading
MANKIND Forecast
MANKIND Forecasts
Price
Revenue
Earnings
MANKIND Share Price Forecast
MANKIND Share Price Forecast
All values in ₹
All values in ₹
MANKIND Company Revenue Forecast
MANKIND Company Revenue Forecast
All values in ₹ Thousand cr.
All values in ₹ Thousand cr.
MANKIND Stock EPS (Earnings Per Share) Forecast
MANKIND Stock EPS (Earnings Per Share) Forecast
All values in ₹
All values in ₹
MANKIND
MANKIND
Income
Balance Sheet
Cash Flow
MANKIND Income Statement
MANKIND Income Statement
| Financial Year | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 5,987.19 | 6,397.06 | 7,992.04 | 8,890.42 | 10,556.85 | 12,761.00 | 14,063.65 | |||||||
| Raw Materials | 1,888.53 | 2,028.00 | 2,871.32 | 2,622.90 | 3,252.14 | 3,672.04 | 10,282.73 | |||||||
| Power & Fuel Cost | 79.96 | 82.53 | 103.13 | 108.96 | 125.16 | 149.49 | ||||||||
| Employee Cost | 1,335.53 | 1,415.78 | 1,620.59 | 1,918.47 | 2,260.60 | 2,692.37 | ||||||||
| Selling & Administrative Expenses | 885.85 | 1,086.44 | 1,410.01 | 1,616.92 | 1,870.54 | 2,447.80 | ||||||||
| Operating & Other expenses | 237.29 | -47.44 | -214.04 | 580.25 | 236.83 | 225.27 | ||||||||
| EBITDA | 1,560.03 | 1,831.75 | 2,201.03 | 2,042.92 | 2,811.58 | 3,574.03 | 3,780.92 | |||||||
| Depreciation/Amortization | 99.06 | 118.97 | 166.62 | 325.92 | 378.42 | 621.22 | 858.54 | |||||||
| PBIT | 1,460.97 | 1,712.78 | 2,034.41 | 1,717.00 | 2,433.16 | 2,952.81 | 2,922.38 | |||||||
| Interest & Other Items | 23.24 | 21.16 | 59.80 | 45.76 | 34.24 | 431.95 | 751.80 | |||||||
| PBT | 1,437.73 | 1,691.62 | 1,974.61 | 1,671.24 | 2,398.92 | 2,520.86 | 2,170.58 | |||||||
| Taxes & Other Items | 407.31 | 426.19 | 541.12 | 389.39 | 486.02 | 529.90 | 419.75 | |||||||
| Net Income | 1,030.42 | 1,265.43 | 1,433.49 | 1,281.85 | 1,912.90 | 1,990.96 | 1,750.83 | |||||||
| EPS | 25.72 | 31.59 | 35.78 | 32.00 | 47.75 | 48.97 | 42.44 | |||||||
| DPS | 0.00 | 7.60 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | |||||||
| Payout ratio | 0.00 | 0.24 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 |
MANKIND Company Updates
Investor Presentation
MANKIND Stock Peers
MANKIND Past Performance & Peer Comparison
MANKIND Past Performance & Peer Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Mankind Pharma Ltd | 45.75 | 6.25 | — |
| Sun Pharmaceutical Industries Ltd | 39.92 | 6.02 | 0.88% |
| Torrent Pharmaceuticals Ltd | 67.21 | 16.92 | 0.84% |
| Cipla Ltd | 23.30 | 3.93 | 1.05% |
MANKIND Stock Price Comparison
Compare MANKIND with any stock or ETFMANKIND Holdings
MANKIND Shareholdings
MANKIND Promoter Holdings Trend
MANKIND Promoter Holdings Trend
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant
MANKIND Institutional Holdings Trend
MANKIND Institutional Holdings Trend
In last 3 months, retail holding in the company has almost stayed constant
In last 3 months, foreign institutional holding of the company has almost stayed constant
MANKIND Shareholding Pattern
MANKIND Shareholding Pattern
MANKIND Shareholding History
MANKIND Shareholding History
Mutual Funds Invested in MANKIND
Mutual Funds Invested in MANKIND
No mutual funds holding trends are available
Top 5 Mutual Funds holding Mankind Pharma Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 1.0661% | Percentage of the fund’s portfolio invested in the stock 1.78% | Change in the portfolio weight of the stock over the last 3 months -0.20% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 25/49 (-2) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.6731% | Percentage of the fund’s portfolio invested in the stock 1.54% | Change in the portfolio weight of the stock over the last 3 months 0.30% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 21/54 (+6) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.3484% | Percentage of the fund’s portfolio invested in the stock 0.90% | Change in the portfolio weight of the stock over the last 3 months -0.07% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 35/105 (-3) |
Compare 3-month MF holding change on Screener
smallcases containing MANKIND stock
smallcases containing MANKIND stock
A smallcase is a basket of stocks/ETFs that represents an idea or theme.Diversify your risk and buy smallcases that have Mankind Pharma Ltd
MANKIND Events
MANKIND Events
MANKIND Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
MANKIND Dividend Trend
No dividend trend available
MANKIND Upcoming Dividends
MANKIND Upcoming Dividends
No upcoming dividends are available
MANKIND Past Dividends
MANKIND Past Dividends
Cash Dividend
Ex DateEx DateAug 8, 2025
Dividend/Share
₹1.00
Ex DateEx Date
Aug 8, 2025
MANKIND Stock News & Opinions
MANKIND Stock News & Opinions
Mankind Pharma has allotted 46,582 equity shares under ESOP on 26 November 2025. With this allotment, the paid up equity share capital has increased to 41,28,05,072 equity shares having face value of Re 1/- each. Powered by Capital Market - Live
Mankind Pharma Ltd dropped for a fifth straight session today. The stock is quoting at Rs 2222.3, down 0.64% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is up around 0.14% on the day, quoting at 25609.05. The Sensex is at 83614.62, up 0.09%.Mankind Pharma Ltd has eased around 9.02% in last one month.Meanwhile, Nifty Pharma index of which Mankind Pharma Ltd is a constituent, has increased around 0.57% in last one month and is currently quoting at 22379.85, down 0.22% on the day. The volume in the stock stood at 2.28 lakh shares today, compared to the daily average of 3.64 lakh shares in last one month. The benchmark November futures contract for the stock is quoting at Rs 2231.5, down 0.72% on the day. Mankind Pharma Ltd tumbled 15.25% in last one year as compared to a 7.23% rally in NIFTY and a 0.81% spurt in the Nifty Pharma index.The PE of the stock is 55.39 based on TTM earnings ending September 25.Powered by Capital Market - Live
Net profit of Mankind Pharma declined 21.72% to Rs 511.51 crore in the quarter ended September 2025 as against Rs 653.47 crore during the previous quarter ended September 2024. Sales rose 20.77% to Rs 3697.16 crore in the quarter ended September 2025 as against Rs 3061.43 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales3697.163061.43 21 OPM %24.9227.67 - PBDT845.84951.72 -11 PBT624.02851.23 -27 NP511.51653.47 -22 Powered by Capital Market - Live
Mankind Pharma has received reaffirmation in credit ratings from CRISIL at CRISIL AA+/ Stable / CRISIL A1+. Powered by Capital Market - Live
Mankind Pharma will hold a meeting of the Board of Directors of the Company on 6 November 2025.Powered by Capital Market - Live
Mankind Pharma Ltd fell for a fifth straight session today. The stock is quoting at Rs 2496.5, down 1.18% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is down around 0.54% on the day, quoting at 24755.4. The Sensex is at 80723.46, down 0.54%.Mankind Pharma Ltd has gained around 0.91% in last one month.Meanwhile, Nifty Pharma index of which Mankind Pharma Ltd is a constituent, has eased around 1.23% in last one month and is currently quoting at 21977.7, down 1.99% on the day. The volume in the stock stood at 2.14 lakh shares today, compared to the daily average of 3.32 lakh shares in last one month. The benchmark September futures contract for the stock is quoting at Rs 2494.1, down 1.24% on the day. Mankind Pharma Ltd tumbled 3.68% in last one year as compared to a 5.44% slide in NIFTY and a 8.41% fall in the Nifty Pharma index.The PE of the stock is 57.48 based on TTM earnings ending June 25.Powered by Capital Market - Live
Mankind Pharma has allotted 29,742 equity shares of face value of Re. 1/- each of the Company to the eligible employees who have exercised their options pursuant to the ESOP Plan. These shares shall rank pari-passu with the existing equity shares of the Company. Consequent to the aforesaid allotment, the paid-up share capital of the Company has increased from 41,27,28,748 Equity Shares to 41,27,58,490 Equity Shares having face value of Re. 1/- each.Powered by Capital Market - Live
Mankind Pharma Ltd is up for a third straight session in a row. The stock is quoting at Rs 2580.7, up 2.96% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.3% on the day, quoting at 25125.75. The Sensex is at 82155.87, up 0.36%. Mankind Pharma Ltd has dropped around 3.36% in last one month. Meanwhile, Nifty Pharma index of which Mankind Pharma Ltd is a constituent, has dropped around 0.59% in last one month and is currently quoting at 21969.5, up 0.94% on the day. The volume in the stock stood at 8.44 lakh shares today, compared to the daily average of 5.46 lakh shares in last one month. The benchmark August futures contract for the stock is quoting at Rs 2586.9, up 2.94% on the day. Mankind Pharma Ltd is up 11.26% in last one year as compared to a 1.27% gain in NIFTY and a 1.65% gain in the Nifty Pharma index.The PE of the stock is 57.14 based on TTM earnings ending June 25.Powered by Capital Market - Live
Mankind Pharma Ltd is down for a fifth straight session today. The stock is quoting at Rs 2435.4, down 1.28% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is up around 0.45% on the day, quoting at 24473.2. The Sensex is at 80206.91, up 0.44%.Mankind Pharma Ltd has lost around 9.68% in last one month.Meanwhile, Nifty Pharma index of which Mankind Pharma Ltd is a constituent, has eased around 3.79% in last one month and is currently quoting at 21402.15, up 0.75% on the day. The volume in the stock stood at 2.26 lakh shares today, compared to the daily average of 6.22 lakh shares in last one month. The benchmark August futures contract for the stock is quoting at Rs 2451.9, down 0.9% on the day. Mankind Pharma Ltd jumped 13.17% in last one year as compared to a 0.52% rally in NIFTY and a 2.9% fall in the Nifty Pharma index.The PE of the stock is 56.23 based on TTM earnings ending June 25.Powered by Capital Market - Live
Net profit of Mankind Pharma declined 18.30% to Rs 438.32 crore in the quarter ended June 2025 as against Rs 536.49 crore during the previous quarter ended June 2024. Sales rose 24.50% to Rs 3570.35 crore in the quarter ended June 2025 as against Rs 2867.85 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales3570.352867.85 24 OPM %23.7223.42 - PBDT759.17764.03 -1 PBT540.49661.34 -18 NP438.32536.49 -18 Powered by Capital Market - Live

Over the last 5 years, revenue has grown at a yearly rate of 16.34%, vs industry avg of 10.03%
Over the last 5 years, market share increased from 2.38% to 3.03%
Over the last 5 years, net income has grown at a yearly rate of 14.08%, vs industry avg of 20.02%